At the convergence of biotechnology and nanotechnology, a new project to map the active human brain may eventually lead to an understanding of human perception and consciousness, as well as therapies for neurological disorders such as Alzheimer’s disease, schizophrenia and autism.
New programs exploring novel approaches to cell-to-cell communication and understanding undiagnosed diseases, which represent challenges or scientific opportunities for a wide array of health research, are the latest priorities for the National Institutes of Health Common Fund. The funding was announced today by NIH Director Francis S. Collins, M.D., Ph.D., after he received broad community input and recommendations from institute and center directors at NIH. The Common Fund targets strategic investments that have the potential for rapid and significant impact. The programs are scheduled to begin during fiscal year 2013.
TED, which stands for Technology, Entertainment, Design, is a nonprofit devoted to “Ideas Worth Spreading.” The annual TED conference brings together some of the world’s most fascinating people to talk briefly about science, business, the arts and global issues facing our world. TEDMED, an independent event operating under license from the TED conference, is a three day annual conference where cutting-edge science and technology leaders “connect, understand and inspire” to advance the art of health and medicine with new ideas, the latest science and innovative technology.
Francis Collins, Director of the National Institutes of Health (NIH), said last month that he is moving ahead with a plan to create a new center focused on translational medicine, presently called the National Center for the Advancement of Translational Sciences (NCATS) . The strategy comes at a time of mounting frustration from researchers that the abundance of new information about the molecular basis of many diseases hasn’t led to the development of new therapies.